A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases

BACKGROUND: Chemotherapy may improve survival in patients undergoing resection of colorectal liver metastases (CLM). Neoadjuvant chemotherapy may help identify patients with occult extrahepatic disease (averting unnecessary metastasectomy), and it provides in vivo chemosensitivity data. METHODS: A p...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bathe, Oliver F, Ernst, Scott, Sutherland, Francis R, Dixon, Elijah, Butts, Charles, Bigam, David, Holland, David, Porter, Geoffrey A, Koppel, Jennifer, Dowden, Scot
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2009
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2693527/
https://ncbi.nlm.nih.gov/pubmed/19457245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-9-156
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires